The global neoantigen cancer vaccine market is witnessing an extraordinary surge, driven by pivotal advances in immunotherapy and increasing investments in healthcare research and development (R&D). With the growing understanding of cancer's molecular mechanisms and the promise of personalized medicine, neoantigen cancer vaccines are poised to become a cornerstone in cancer treatment,...